RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea-Reference-Cited by-同舟云学术

RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea

Published:2017-04 Issue: Volume:49 Page:111-115
ISSN:1567-1348
Container-title:Infection, Genetics and Evolution
language:en
Short-container-title:Infection, Genetics and Evolution

Author:

Oh Tae Sang,Kim Young Jin,Kang Hee Yoon,Kim Chang-Ki,Cho Sun Young,Lee Hee Joo

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology

Reference31 articles.

1. Molecular cloning and characterization of tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis;Ainsa;J. Bacteriol.,1998

2. Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic;Ball;Biochem. Biophys. Res. Commun.,1980

3. Identification of an ABC transporter gene that exhibits mRNA level overexpression in fluoroquinolone-resistant Mycobacterium smegmatis;Banerjee;FEBS Lett.,1998

4. Evidence that phosphate specific transporter is amplified in a fluoroquinolone resistant Mycobacterium smegmatis;Bhatt;Eur. J. Biochem.,2000

5. MIQE precis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments;Bustin;BMC Mol. Biol.,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efflux pump effects on levofloxacin resistance in Mycobacterium abscessus;Antimicrobial Agents and Chemotherapy;2024-05-02

2. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand;PLOS ONE;2023-11-22

3. Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing;Frontiers in Cellular and Infection Microbiology;2023-06-22

4. Low-cost anti-mycobacterial drug discovery using engineered E. coli;Nature Communications;2022-07-07

5. Rescue of susceptibility to second-line drugs in resistant clinical isolates of Mycobacterium tuberculosis;Future Microbiology;2022-05